Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer

By Incrocci L.   Hop W.C.J.   Slob A.K.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 116-120

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study

By Caruso S.   Intelisano G.   Farina M.   DiMari L.   Agnello C.   Giammusso B.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 922-927

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction

By Dula E.   Keating W.   Siami P.F.   Edmonds A.   O'neil J.   Buttler S.  

Urology, Vol. 56, Iss. 1, 2000-07 ,pp. : 130-135

Elsevier

Access to resources Recommend Favorite

The Role of Apomorphine SL in the Treatment of Erectile Dysfunction

By Montorsi F.  

European Urology Supplements, Vol. 1, Iss. 3, 2002-05 ,pp. : 4-11

Elsevier

Access to resources Recommend Favorite

The efficacy of sildenafil in different etiologies of erectile dysfunction

By Başar Murat   Tekdoğan Ümit   Yılmaz Erdal   Başar Halil   Atan Ali   Batislam Ertan  

International Urology and Nephrology, Vol. 32, Iss. 3, 2001-09 ,pp. : 403-407

Springer Publishing Company

Access to resources Recommend Favorite